Cargando…

Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease

Crohn’s disease is difficult to manage and often requires multiple medications. While these drugs vastly improve quality of life, physicians must monitor for adverse events. We report a case of a flare of inverse psoriasis after 15 months of treatment with ustekinumab. This is the third reported cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwin, Evan, Deshpande, Amar, Lev-Tov, Hadar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013682/
https://www.ncbi.nlm.nih.gov/pubmed/29951562
http://dx.doi.org/10.14309/crj.2018.47
_version_ 1783334061964525568
author Darwin, Evan
Deshpande, Amar
Lev-Tov, Hadar
author_facet Darwin, Evan
Deshpande, Amar
Lev-Tov, Hadar
author_sort Darwin, Evan
collection PubMed
description Crohn’s disease is difficult to manage and often requires multiple medications. While these drugs vastly improve quality of life, physicians must monitor for adverse events. We report a case of a flare of inverse psoriasis after 15 months of treatment with ustekinumab. This is the third reported case of a flare of drug-induced psoriasis with ustekinumab, and it is the first reported case with an inverse presentation; however, the clinical picture is confounded by concomitant use of hydroxychloroquine. Inverse psoriasis is a rare variant of drug-induced psoriasis of which physicians must be cognizant while treating patients with Crohn’s disease.
format Online
Article
Text
id pubmed-6013682
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American College of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-60136822018-06-27 Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease Darwin, Evan Deshpande, Amar Lev-Tov, Hadar ACG Case Rep J Case Report Crohn’s disease is difficult to manage and often requires multiple medications. While these drugs vastly improve quality of life, physicians must monitor for adverse events. We report a case of a flare of inverse psoriasis after 15 months of treatment with ustekinumab. This is the third reported case of a flare of drug-induced psoriasis with ustekinumab, and it is the first reported case with an inverse presentation; however, the clinical picture is confounded by concomitant use of hydroxychloroquine. Inverse psoriasis is a rare variant of drug-induced psoriasis of which physicians must be cognizant while treating patients with Crohn’s disease. American College of Gastroenterology 2018-06-20 /pmc/articles/PMC6013682/ /pubmed/29951562 http://dx.doi.org/10.14309/crj.2018.47 Text en Copyright © Darwin et al. This is an open-access article. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Case Report
Darwin, Evan
Deshpande, Amar
Lev-Tov, Hadar
Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
title Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
title_full Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
title_fullStr Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
title_full_unstemmed Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
title_short Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
title_sort development of drug-induced inverse psoriasis in a patient with crohn’s disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013682/
https://www.ncbi.nlm.nih.gov/pubmed/29951562
http://dx.doi.org/10.14309/crj.2018.47
work_keys_str_mv AT darwinevan developmentofdruginducedinversepsoriasisinapatientwithcrohnsdisease
AT deshpandeamar developmentofdruginducedinversepsoriasisinapatientwithcrohnsdisease
AT levtovhadar developmentofdruginducedinversepsoriasisinapatientwithcrohnsdisease